In vivo administration of interferon does not cause marrow aplasia in mice with a targeted disruption of FANCC

Author： Kurre P.   Anandakumar P.   Grompe M.   Kiem H.-P.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.30, Iss.11, 2002-11, pp. : 1257-1262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo

By Hanson P.   Mathews V.   Marrus S.H.   Graubert T.A.  

Experimental Hematology, Vol. 31, Iss. 2, 2003-02 ,pp. : 159-167

Elsevier

Access to resources Recommend Favorite

Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential

By Ramirez M.   Diaz M.A.   Madero L.   Bueren J.A.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1153-1157

Elsevier

Access to resources Recommend Favorite

Quantum Dot-Based Nanoprobes for In Vivo Targeted Imaging

By  

Current Molecular Medicine, Vol. 13, Iss. 10, 2013-01 ,pp. : 1549-1567

Bentham Science Publishers

Access to resources Recommend Favorite

Immune responses to naturally acquired Pneumocystis carinii in gene disruption mutant mice

By Hanano R.   Kaufmann S.H.E.  

Research in Immunology, Vol. 149, Iss. 4, 1998-05 ,pp. : 429-435

Elsevier

Access to resources Recommend Favorite

Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells - An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta

By Bergh F.T.   Dayyani F.   Ziegler-Heitbrock L.  

Journal of Neuroimmunology, Vol. 146, Iss. 1, 2004-01 ,pp. : 176-188

Elsevier

Access to resources Recommend Favorite